A detailed history of Alps Advisors Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 22,942 shares of FLGT stock, worth $420,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,942
Previous 23,362 1.8%
Holding current value
$420,068
Previous $458,000 8.73%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$19.6 - $25.06 $8,232 - $10,525
-420 Reduced 1.8%
22,942 $498,000
Q2 2024

Aug 13, 2024

BUY
$19.09 - $22.57 $445,980 - $527,280
23,362 New
23,362 $458,000
Q1 2022

May 16, 2022

SELL
$49.85 - $96.11 $212,012 - $408,755
-4,253 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$77.3 - $105.0 $3,942 - $5,355
51 Added 1.21%
4,253 $428,000
Q3 2021

Nov 15, 2021

BUY
$74.87 - $110.87 $82,431 - $122,067
1,101 Added 35.5%
4,202 $378,000
Q1 2021

May 07, 2021

BUY
$59.3 - $183.85 $183,889 - $570,118
3,101 New
3,101 $300,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $554M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.